ZTEK Zentek Ltd. logo

ZTEK Zentek Ltd.

Healthcare
$0.65-10.03%ClosedMarket Cap: $69.6M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

7.87

P/S

103.79

EV/EBITDA

-12.47

DCF Value

$-0.29

FCF Yield

-6.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

-74.8%

Operating Margin

-928.4%

Net Margin

-857.1%

ROE

-61.3%

ROA

-46.5%

ROIC

-61.5%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$65.2K$-2.5M$
Q2 null$6.2K$-2.4M$
Q1 null$57.8K$-1.4M$
Q4 null$813.6K$-1.8M$

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

CA

Exchange

Beta

0.31

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.

Peers